Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
More Stories
Revealed: Chinese researchers can access half a million UK GP records
About 15% of world’s cropland polluted with toxic metals, say researchers
Rebecca Hendin on life outside our solar system – cartoon